Who owns ADIAL PHARMACEUTICALS INC?
- CUSIP Number: 00688a205
Tip: Access positions for across all investors
Analyze quarterly positions in Adial Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Adial Pharmaceuticals stock
Who bought or sold ADIAL PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 156k | $34k | 0% | Dec 2025 |
|
| Northern Trust | 66k | $15k | 100% | Dec 2025 |
|
| Virtu Financial | 64k | $14k | 100% | Dec 2025 |
|
| XTX Topco | 52k | $12k | 100% | Dec 2025 |
|
| Susquehanna International | 12k | $2.7k | 100% | Dec 2025 |
|
| Tower Research Capital | 1.3k | $295.020000 | -2% | Dec 2025 |
|
Who sold out of Adial Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Citadel Advisors | Dec 2025 | 220k | $48k |
| Geode Capital Management | Dec 2025 | 156k | $34k |
| Jane Street | Dec 2025 | 122k | $27k |
| Manchester Capital Management | Dec 2025 | 48k | $11k |
| BlackRock | Dec 2025 | 28k | $6.1k |
| Intl Fcstone | Dec 2025 | 20k | $4.3k |
| Two Sigma Securities | Dec 2025 | 17k | $3.8k |
| Private Management Group | Dec 2025 | 10k | $2.2k |
| UBS Group | Dec 2025 | 9.2k | $2.0k |